CureVac Says Its Not Giving Up on a Covid-19 Vaccine and The Shares Are Soaring.

[ad_1] Text dimension CureVac inventory dived Thursday after information that its Covid-19 vaccine candidate was a failure. (Photo by Jeroen

Read more

CureVac Stock Tumbles After Vaccine Failure. Why More Pain May Be Coming.

[ad_1] Text measurement An worker checked bottles of vaccine diluent at a CureVac provider in France in April. Guillaume Souvant/AFP

Read more

CureVac Started the Day Worth More Than Novavax. Then Its Vaccine News Hit.

[ad_1] Text measurement CureVac’s vaccine was 47% efficient at stopping Covid-19 signs in a trial of 40,000 volunteers. JEROEN JUMELET/ANP/AFP

Read more